---
title: "Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall | EVO Stock News"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/285031970.md"
description: "Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall | EVO Stock News"
datetime: "2026-05-03T21:50:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/285031970.md)
  - [en](https://longbridge.com/en/news/285031970.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/285031970.md)
---

# Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall | EVO Stock News

Evotec Announces Nomination of First Preclinical Development Candidate in Dermatology Collaboration with Almirall | EVO Stock News

### Related Stocks

- [EVO.US](https://longbridge.com/en/quote/EVO.US.md)
- [IBBQ.US](https://longbridge.com/en/quote/IBBQ.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [XLV.US](https://longbridge.com/en/quote/XLV.US.md)
- [VHT.US](https://longbridge.com/en/quote/VHT.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [EVT.DE](https://longbridge.com/en/quote/EVT.DE.md)

## Related News & Research

- [<![CDATA[Regeneron Enters $2.3 Billion Collaboration with Parabilis Medicines to Discover & Develop Multiple Therapeutic Candidates]]>](https://longbridge.com/en/news/286787081.md)
- [NeOnc Advances Glioma Programs and Strengthens Financial Position](https://longbridge.com/en/news/286826865.md)
- [<![CDATA[Pharmaceutical Executive Daily: FDA Approves Baxdrostat]]>](https://longbridge.com/en/news/286807703.md)
- [Eton Pharmaceuticals Adds Another 2026 Launch As It Secures U.S. Rights To IMPAVIDO](https://longbridge.com/en/news/287025596.md)
- [Incyte expands Genesis Molecular AI collaboration, pays USD 120 million upfront](https://longbridge.com/en/news/287060301.md)